Evaluation of Serum Transaminases Levels In Transfused β-Thalssaemia Major Patients

Authors

  • Saad A. Mustafa Dept. of Pathology, Collage of Medicine, University of Baghdad.

DOI:

https://doi.org/10.32007/jfacmedbagdad.5211059

Keywords:

Serum Transminases, Thalassemia Major, Transfusion-Dependant.

Abstract

Background: β-thalassemia major is a genetic disorder characterized by reduced rate of β-globin chain production. Clinically, β-thalassemia major is a severe, transfusion-dependant disorder; repeated blood transfusion will lead eventually to chronic liver disease.
Patients and Methods: One hundred patients ; 56 males and 44 females who were known cases with β-thalassemia major on regular blood transfusion, aged between 6 months and 18 years, were studied in a private pathology laboratory, between January 2002-January 2006.Blood was drawn to estimate serum glutamic pyruvate transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) levels.
Results: Sixty-six patients (66%) had elevated SGPT and SGOT levels ranging between two and more than five fold increase than normal.Thirty-four patients (34%) had normal SGPT and SGOT values of less than 40 i.u. /L. The levels of SGPT and SGOT were significantly higher in splenectomised patients than nonsplenectomised.
Conclusion: Serum transaminases were elevated in (66%) of transfused patients with B-thalassemia major.

Downloads

Download data is not yet available.

Downloads

Published

04.04.2010

How to Cite

1.
Mustafa SA. Evaluation of Serum Transaminases Levels In Transfused β-Thalssaemia Major Patients. J Fac Med Baghdad [Internet]. 2010 Apr. 4 [cited 2024 Nov. 22];52(1):60-1. Available from: https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1059

Publication Dates

Similar Articles

1-10 of 402

You may also start an advanced similarity search for this article.